Cytomegalovirus

Recent findings from Chimerix, Inc. highlight research in cytomegalovirus

Published in AIDS Weekly, January 12th, 2009

"CMX001 is a lipid (1-O-hexadecyloxypropyl) conjugate of the phosphonate nucleotide analogue cidofovir (CDV). CDV, which is approved by the FDA for the treatment of cytomegalovirus (CMV)-induced retinitis in AIDS patients, is active against all five families of double-stranded DNA (dsDNA) viruses that cause human morbidity and mortality," investigators in the United States report.

"However, the clinical utility of the drug is limited by the need for administration by intravenous infusion and the possibility of acute nephrotoxicity. The formation of the lipid conjugate increases in vitro antiviral activity up to a thousandfold, promotes high oral bioavailability and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2009-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry